Advancing microbiome therapeutics: Vedanta Biosciences raises US$45.5m in funding

The company has generated a pipeline of microbial treatment programs for infectious diseases, autoimmune diseases, allergies and cancer

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

07 Feb 2020 --- A new collaboration between Danone Nutricia Research and the University of California, San Diego’s Microsetta Initiative is recruiting hundreds of US citizens... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

06 Feb 2020 --- Gut health is fast becoming the cornerstone of human health with research highlighting its influence on a range of health areas. From brain to skin health and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

03 Feb 2020 --- Biopharmaceutical company Aimmune Therapeutics has received US Food and Drug Administration (FDA) approval for Palforzia, the first approved oral immunotherapy... Read More

FormattedPicture

PACKAGING & TECHNOLOGY NEWS

03 Feb 2020 --- Creative agency B&B studio has designed the identity of new gut health-boosting granola brand Bio&Me, co-founded by gut health expert Dr. Megan Rossi, to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

30 Jan 2020 --- Digestive health soda brand Olipop has raised nearly US$10 million in its first major financing round. The news was confirmed by David Lester, Olipop’s... Read More

trans